92 related articles for article (PubMed ID: 29442375)
1. Characterization of neuropeptide K processing in rat spinal cord S9 fractions using high-resolution quadrupole-Orbitrap mass spectrometry.
Salem JB; Nkambeu B; Beaudry F
Biomed Chromatogr; 2018 Jun; 32(6):e4204. PubMed ID: 29442375
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Substance P processing in mouse spinal cord S9 fractions using high-resolution Quadrupole-Orbitrap mass spectrometry.
Saidi M; Kamali S; Beaudry F
Neuropeptides; 2016 Oct; 59():47-55. PubMed ID: 27344070
[TBL] [Abstract][Full Text] [Related]
3. Tachykinins Processing is Significantly Impaired in PC1 and PC2 Mutant Mouse Spinal Cord S9 Fractions.
Saidi M; Kamali S; Ruiz AO; Beaudry F
Neurochem Res; 2015 Nov; 40(11):2304-16. PubMed ID: 26373413
[TBL] [Abstract][Full Text] [Related]
4. Targeted high-resolution quadrupole-Orbitrap mass spectrometry analyses reveal a significant reduction of tachykinin and opioid neuropeptides level in PC1 and PC2 mutant mouse spinal cords.
Saidi M; Beaudry F
Neuropeptides; 2017 Oct; 65():37-44. PubMed ID: 28476408
[TBL] [Abstract][Full Text] [Related]
5. Regional distribution of neuropeptide K and other tachykinins (neurokinin A, neurokinin B and substance P) in rat central nervous system.
Arai H; Emson PC
Brain Res; 1986 Dec; 399(2):240-9. PubMed ID: 2435360
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the hypothalamo-pituitary-gonadal axis and the pineal gland by neurokinin A, neuropeptide K and neuropeptide gamma.
Debeljuk L; Lasaga M
Peptides; 1999; 20(2):285-99. PubMed ID: 10422885
[TBL] [Abstract][Full Text] [Related]
7. Bronchoconstrictor and hypotensive effects in relation to pharmacokinetics of tachykinins in the guinea-pig--evidence for extraneuronal cleavage of neuropeptide K to neurokinin A.
Martling CR; Theodorsson-Norheim E; Norheim I; Lundberg JM
Naunyn Schmiedebergs Arch Pharmacol; 1987 Aug; 336(2):183-9. PubMed ID: 2825041
[TBL] [Abstract][Full Text] [Related]
8. Multiple molecular forms of tachykinins in rat spinal cord: a study comparing different extraction methods.
Brodin E; Rosén A; Theodorsson E; Jonczyk A; Sandberg BE; Brodin K
Regul Pept; 1994 Jul; 52(2):97-110. PubMed ID: 7526421
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of neuropeptide K and neuropeptide gamma with neurokinin A at NK2 receptors in the hamster urinary bladder.
van Giersbergen PL; Shatzer SA; Burcher E; Buck SH
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):51-6. PubMed ID: 1311427
[TBL] [Abstract][Full Text] [Related]
10. Regional distribution of neuropeptide gamma and other tachykinin peptides derived from the substance P gene in the rat.
Takeda Y; Takeda J; Smart BM; Krause JE
Regul Pept; 1990 May; 28(3):323-33. PubMed ID: 1696018
[TBL] [Abstract][Full Text] [Related]
11. Tachykinin systems in the spinal cord and basal ganglia: influence of neonatal capsaicin treatment or dopaminergic intervention on levels of peptides, substance P-encoding mRNAs, and substance P receptor mRNA.
Sivam SP; Krause JE
J Neurochem; 1992 Dec; 59(6):2278-84. PubMed ID: 1279124
[TBL] [Abstract][Full Text] [Related]
12. Characterization of endoproteolytic processing of dynorphins by proprotein convertases using mouse spinal cord S9 fractions and mass spectrometry.
Orduna AR; Beaudry F
Neuropeptides; 2016 Jun; 57():85-94. PubMed ID: 26578270
[TBL] [Abstract][Full Text] [Related]
13. Diverse effects of tachykinins on luteinizing hormone release in male rats: mechanism of action.
Kalra PS; Sahu A; Bonavera JJ; Kalra SP
Endocrinology; 1992 Sep; 131(3):1195-201. PubMed ID: 1380435
[TBL] [Abstract][Full Text] [Related]
14. Neurokinin A, neurokinin B and neuropeptide K in the rabbit iris: a study comparing different extraction methods.
Beding-Barnekow B; Brodin E
Regul Pept; 1989 May; 25(2):199-206. PubMed ID: 2547226
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of tachykinin septide-sensitive binding sites in the rat submaxillary gland.
Beaujouan JC; Saffroy M; Torrens Y; Sagan S; Glowinski J
Peptides; 1999 Nov; 20(11):1347-52. PubMed ID: 10612450
[TBL] [Abstract][Full Text] [Related]
16. The role of the amino-terminal domain of tachykinins in neurokinin-1 receptor signaling and desensitization.
Vigna SR
Neuropeptides; 2003 Feb; 37(1):30-5. PubMed ID: 12637033
[TBL] [Abstract][Full Text] [Related]
17. The effect of selective serotonergic neurotoxin treatment on tachykinin levels in the rat ventral spinal cord.
Franck J; Brodin E; Fried K; Rosén A; Yamamoto Y; Fried G
Neuroscience; 1991; 45(2):339-45. PubMed ID: 1722290
[TBL] [Abstract][Full Text] [Related]
18. Targeted liquid chromatography quadrupole ion trap mass spectrometry analysis of tachykinin related peptides reveals significant expression differences in a rat model of neuropathic pain.
Pailleux F; Vachon P; Lemoine J; Beaudry F
Neuropeptides; 2013 Aug; 47(4):261-71. PubMed ID: 23490005
[TBL] [Abstract][Full Text] [Related]
19. Relative bronchoconstrictor activity of neurokinin A and neurokinin A fragments in guinea pigs.
Shore SA; Drazen JM
J Appl Physiol (1985); 1991 Aug; 71(2):452-7. PubMed ID: 1657859
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of multiple reaction monitoring cubed for the analysis of tachykinin related peptides in rat spinal cord using a hybrid triple quadrupole-linear ion trap mass spectrometer.
Pailleux F; Beaudry F
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb; 947-948():164-7. PubMed ID: 24434561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
